Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study
2016 ◽
Vol 196
(3)
◽
pp. 801-808
◽
2008 ◽
Vol 4
(6)
◽
pp. 428-433
◽
2014 ◽
Vol 13
(1)
◽
pp. e693
◽